ADAMS RESPIRATORY THERAPEUTICS
Adams Respiratory Therapeutics, Inc., a specialty pharmaceutical company, engages in the development, commercialization, and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders. It sells its products to drug wholesalers, retail drug stores, mass merchandisers, and grocery stores in the United States.
ADAMS RESPIRATORY THERAPEUTICS
Industry:
Commercial Health Care Marketing Pharmaceutical
Founded:
1997-01-01
Address:
Chester, New Jersey, United States
Country:
United States
Status:
Active
Contact:
(908)879-1400
Similar Organizations
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
Current Advisors List
Board_member
Stock Details
More informations about "Adams Respiratory Therapeutics"
Adams Respiratory Therapeutics - PitchBook
What is the size of Adams Respiratory Therapeutics? Adams Respiratory Therapeutics has 501 total employees. What industry is Adams Respiratory Therapeutics in? Adams Respiratory …See details»
Adams Respiratory Therapeutics, Inc. - synapse.patsnap.com
Aug 30, 2023 Explore Adams Respiratory Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, Drug:Erdosteine.See details»
Adams Respiratory to be acquired for $2.3 billion - MarketWatch
Dec 10, 2007 NEW YORK (MarketWatch) - Drug maker Adams Respiratory Therapeutics Inc., maker of Mucinex, said Monday it would be acquired by Reckitt Benckiser Group for $2.3 …See details»
Michael Valentino: Positions, Relations and Network
Dec 31, 2001 Michael J. Valentino was the founder of Adams Respiratory Therapeutics, Inc. (founded in 2003) where he held the title of President & Chief Executive Officer. He is currently …See details»
Adams Respiratory Therapeutics - Funding, Financials, Valuation
Adams Respiratory Therapeutics is registered under the ticker NASDAQ:ARXT . Their stock opened with $17.00 in its Jul 21, 2005 IPO. Stock Symbol NASDAQ:ARXTSee details»
Organization | Adams Respiratory Therapeutics
Adams Respiratory Therapeutics Report issue. Contributed to NME For profit Phase 2 Phase 4. Founded: Chester NJ United States ... Organization Overview. First Clinical Trial. 2006 …See details»
ADAMS RESPIRATORY THERAPEUTICS, INC. - SEC.gov
Incorporation or Organization) (I.R.S. Employer Identification No.) 4 Mill Ridge Lane Chester, New Jersey 07930 (Address of principal executive offices including zip code) (908) 879-1400 ...See details»
Adams Respiratory Therapeutics Company Profile - Datanyze
Adams Respiratory Therapeutics Profile and History Adams Respiratory Therapeutics, Inc. is a specialty pharmaceutical company focused on the late-stage development, commercialization …See details»
Adams Respiratory Therapeutics - Crunchbase
Adams Respiratory Therapeutics is a pharmaceutical company for late-stage development, commercialization, and marketing. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
ADAMS RESPIRATORY THERAPUETICS, INC. - SEC.gov
Sublease Agreement and Lessor Consent dated April 1, 2004 between Adams Laboratories, Inc., Cardinal Health PTS, LLC and The Estate of James Campbell, Deceased for Adams …See details»
Adams Respiratory Therapeutics - Products, Competitors, …
Oct 2, 2024 Adams is a specialty pharmaceutical company focused on late stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the …See details»
Working at Adams Respiratory Therapeutics - Zippia
18% of Adams Respiratory Therapeutics employees are Hispanic or Latino. 14% of Adams Respiratory Therapeutics employees are Black or African American. The average employee at …See details»
ADAMS RESPIRATORY THERAPEUTICS, INC. - SEC.gov
This proxy statement is first being mailed on or about November 3, 2006, to the stockholders of Adams Respiratory Therapeutics, Inc., a Delaware corporation (“Adams,” “we,” “us,” or the …See details»
Reckitt acquires Adams Respiratory Therapeutics - 2008-01-30 ...
Adams Respiratory Therapeutics Adams Respiratory Therapeutics is a pharmaceutical company for late-stage development, commercialization, and marketing. Acquiring Organization: Reckitt …See details»
Adams Respiratory Therapeutics Announces Organizational Changes
Oct 31, 2006 In addition, Adams has reorganized its executive management team, broadening its composition from eight to 15 members, representing the key functional areas of the …See details»
ADAMS RESPIRATORY THERAPEUTICS, INC. - SEC.gov
The tender offer for the outstanding shares of Adams Respiratory Therapeutics, Inc. common stock has not commenced. At the time the offer is commenced, an indirect, wholly owned …See details»
Reckitt Benckiser Plc Completes Acquisition of Adams Respiratory ...
Jan 30, 2008 CHESTER, N.J. and SLOUGH, England, Jan. 30 /PRNewswire/ -- Reckitt Benckiser Group plc (RB.L) (“Reckitt Benckiser”) today announced the successful completion …See details»
Adams Respiratory Therapeutics - Contacts, Employees, Board …
Adams Respiratory Therapeutics is a pharmaceutical company for late-stage development, commercialization, and marketing.See details»
Biological and pharmacological roles of pyroptosis in pulmonary ...
3 days ago Pulmonary fibrosis (PF) is a chronic, inflammatory, progressive fibrotic lung disease characterized by respiratory difficulties, restrictive ventilatory impairment, gas exchange …See details»
Michael J. Valentino - Chairman of the Board - Crunchbase
Michael has spent 30+ years as a healthcare industry executive. He built the start-up Adams Respiratory Therapeutics into a fully integrated specialty pharmaceutical company with more …See details»